|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2019. CA Cancer J Clin. 69:7–34. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
El-Karaksy HM, Mogahed E, El-Sayed R,
El-Raziky M, Sheba M, Besheer M, Elkiki H and Ghita H: Focal
hepatic lesions in Egyptian infants and children: The pediatric
hepatologist perspective. Minerva Pediatr. 70:35–45. 2018.
|
|
3
|
Hartke J, Johnson M and Ghabril M: The
diagnosis and treatment of hepatocellular carcinoma. Semin Diagn
Pathol. 34:153–159. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Li Y, Ruan DY, Jia CC, Zhao H, Wang GY,
Yang Y and Jiang N: Surgical resection versus liver transplantation
for hepatocellular carcinoma within the Hangzhou criteria: A
preoperative nomogram-guided treatment strategy. Hepatobiliary
Pancreat Dis Int. 16:480–486. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gnutzmann D, Kortes N, Sumkauskaite M,
Schmitz A, Weiss KH and Radeleff B: Transvascular therapy of
hepatocellular carcinoma (HCC), status and developments. Minim
Invasive Ther Allied Technol. 27:69–80. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
da Motta Girardi D, Correa TS, Crosara
Teixeira M and Dos Santos Fernandes G: Hepatocellular carcinoma:
Review of targeted and immune therapies. J Gastrointest Cancer.
49:227–236. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lui WY, P'eng FK, Chang YF, Chang TJ, Tsai
TF, Hsu ML, Su TS, Tsay SH, Wu CW, Liu TY, et al: Analysis of
glucocorticoid receptors in human hepatocellular carcinoma and
HepG2 cells. Hepatology. 18:1167–1174. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ray K: Hepatocellular carcinoma: restoring
gluconeogenesis: steroids could treat liver cancer. Nat Rev
Gastroenterol Hepatol. 10:6932013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Woods CP, Hazlehurst JM and Tomlinson JW:
Glucocorticoids and non-alcoholic fatty liver disease. J Steroid
Biochem Mol Biol. 154:94–103. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lee DH, Cheul Oh S, Giles AJ, Jung J,
Gilbert MR and Park DM: Cardiac glycosides suppress the maintenance
of stemness and malignancy via inhibiting HIF-1α in human glioma
stem cells. Oncotarget. 8:40233–40245. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xiang L, Gilkes DM, Chaturvedi P, Luo W,
Hu H, Takano N, Liang H and Semenza GL: Ganetespib blocks HIF-1
activity and inhibits tumor growth, vascularization, stem cell
maintenance, invasion, and metastasis in orthotopic mouse models of
triple-negative breast cancer. J Mol Med (Berl). 92:151–164. 2014.
View Article : Google Scholar
|
|
12
|
Yoon C, Chang KK, Lee JH, Tap WD, Hart CP,
Simon MC and Yoon SS: Multimodal targeting of tumor vasculature and
cancer stem like cells in sarcomas with VEGF A inhibition, HIF 1α
inhibition, and hypoxia activated chemotherapy. Oncotarget.
7:42844–42858. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cui CP, Wong CC, Kai AK, Ho DW, Lau EY,
Tsui YM, Chan LK, Cheung TT, Chok KS, Chan ACY, et al: SENP1
promotes hypoxia-induced cancer stemness by HIF-1α deSUMOylation
and SENP1/HIF-1α positive feedback loop. Gut. 66:2149–2159. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Han X, Wang XL, Li Q, Dong XX, Zhang JS
and Yan QC: HIF-1α SUMOylation affects the stability and
transcriptional activity of HIF-1α in human lens epithelial cells.
Graefes Arch Clin Exp Ophthalmol. 253:1279–1290. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tahmasebi S, Ghorbani M, Savage P,
Gocevski G and Yang XJ: The SUMO conjugating enzyme Ubc9 is
required for inducing and maintaining stem cell pluripotency. Stem
Cells. 32:1012–1020. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wu Y, Guo Z, Wu H, Wang X, Yang L, Shi X,
Du J, Tang B, Li W, Yang L, et al: SUMOylation represses Nanog
expression via modulating transcription factors Oct4 and Sox2. PLoS
One. 7:e396062012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Han ZJ, Feng YH, Gu BH, Li YM and Chen H:
The post-translational modification, SUMOylation, and cancer
(Review). Int J Oncol. 52:1081–1094. 2018.Review. PubMed/NCBI
|
|
18
|
Gupta KJ, Kolbert Z, Durner J, Lindermayr
C, Corpas FJ, Brouquisse R, Barroso JB, Umbreen S, Palma JM,
Hancock JT, et al: Regulating the regulator: Nitric oxide control
of post-translational modifications. New Phytol. Apr 27–2020.Epub
ahead of print. View Article : Google Scholar
|
|
19
|
Li R, Wei J, Jiang C, Liu D, Deng L, Zhang
K and Wang P: Akt SUMOylation regulates cell proliferation and
tumorigenesis. Cancer Res. 73:5742–5753. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ni P, Xu H, Chen C, Wang J, Liu X, Hu Y,
Fan Q, Hou Z and Lu Y: Serum starvation induces DRAM expression in
liver cancer cells via histone modifications within its promoter
locus. PLoS One. 7:e505022012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Polderman JA, Farhang-Razi V, Van Dieren
S, Kranke P, DeVries JH, Hollmann MW, Preckel B and Hermanides J:
Adverse side effects of dexamethasone in surgical patients.
Cochrane Database Syst Rev. 8:CD0119402018.PubMed/NCBI
|
|
22
|
Tang H, Jin Y, Jin S, Tan Z, Peng Z and
Kuang Y: Arsenite inhibits the function of CD133+
CD13+ liver cancer stem cells by reducing PML and Oct4
protein expression. Tumour Biol. 37:14103–14115. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Luo T, Wang L, Wu P, Gong W, Chen W, Zhao
H and Zheng Z: Downregulated vimentin and upregulated E-cadherin in
T1 stage non-small-cell lung cancer: Does it suggest a
mesenchymal-epithelial transition? Neoplasma. 64:693–699. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zilio N, Eifler-Olivi K and Ulrich HD:
Functions of SUMO in the Maintenance of Genome Stability. Adv Exp
Med Biol. 963:51–87. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhao X: SUMO-mediated regulation of
nuclear functions and signaling processes. Mol Cell. 71:409–418.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Pichler A, Fatouros C, Lee H and
Eisenhardt N: SUMO conjugation - a mechanistic view. Biomol
Concepts. 8:13–36. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang L, Zhang T, Fang M, Shen N, Wang D,
Teng J, Fu B, Xie H, Hong Q and Lin H: Podocytes protect glomerular
endothelial cells from hypoxic injury via deSUMOylation of HIF-1α
signaling. Int J Biochem Cell Biol. 58:17–27. 2015. View Article : Google Scholar
|
|
28
|
Gupta P, Ho PC, Huq MM, Ha SG, Park SW,
Khan AA, Tsai NP and Wei LN: Retinoic acid-stimulated sequential
phosphorylation, PML recruitment, and SUMOylation of nuclear
receptor TR2 to suppress Oct4 expression. Proc Natl Acad Sci USA.
105:11424–11429. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Parikh ND, Fu S, Rao H, Yang M, Li Y,
Powell C, Wu E, Lin A, Xing B, Wei L, et al: Risk assessment of
hepatocellular carcinoma in patients with hepatitis C in China and
the USA. Dig Dis Sci. 62:3243–3253. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Mak LY, Cruz-Ramón V, Chinchilla-López P,
Torres HA, LoConte NK, Rice JP, Foxhall LE, Sturgis EM, Merrill JK,
Bailey HH, et al: Global epidemiology, prevention, and management
of hepatocellular carcinoma. Am Soc Clin Oncol Educ Book.
38:262–279. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Pinna AD, Yang T, Mazzaferro V, De Carlis
L, Zhou J, Roayaie S, Shen F, Sposito C, Cescon M, Di Sandro S, et
al: Liver transplantation and hepatic resection can achieve cure
for hepatocellular carcinoma. Ann Surg. 268:868–875. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Akoad ME and Pomfret EA: Surgical
resection and liver transplantation for hepatocellular carcinoma.
Clin Liver Dis. 19:381–399. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Fillat C, Carrió M, Cascante A and Sangro
B: Suicide gene therapy mediated by the Herpes Simplex virus
thymidine kinase gene/Ganciclovir system: Fifteen years of
application. Curr Gene Ther. 3:13–26. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhang JH, Wan MX, Pan BR and Yu B:
Cytotoxicity of HSVtk and hrTNF-alpha fusion genes with IRES in
treatment of gastric cancer. Cancer Biol Ther. 3:1075–1080. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Parada C, Hernández Losa J, Guinea J,
Sánchez-Arévalo V, Fernández Soria V, Alvarez-Vallina L,
Sánchez-Prieto R and Ramón y Cajal S: Adenovirus E1a protein
enhances the cytotoxic effects of the herpes thymidine
kinase-ganciclovir system. Cancer Gene Ther. 10:152–160. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Shang F, Liu M, Li B, Zhang X, Sheng Y,
Liu S, Han J, Li H and Xiu R: The anti-angiogenic effect of
dexamethasone in a murine hepatocellular carcinoma model by
augmentation of gluconeogenesis pathway in malignant cells. Cancer
Chemother Pharmacol. 77:1087–1096. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ogasawara S, Chiba T, Ooka Y, Kanogawa N,
Motoyama T, Suzuki E, Tawada A, Nagai K, Nakagawa T, Sugawara T, et
al: A randomized placebo-controlled trial of prophylactic
dexa-methasone for transcatheter arterial chemoembolization.
Hepatology. 67:575–585. 2018. View Article : Google Scholar
|
|
38
|
Yang H, Seon J, Sung PS, Oh JS, Lee HL,
Jang B, Chun HJ, Jang JW, Bae SH, Choi JY and Yoon SK:
Dexamethasone Prophylaxis to Alleviate Postembolization Syndrome
after Transarterial Chemoembolization for Hepatocellular Carcinoma:
A Randomized, Double Blinded, Placebo Controlled Study. J Vasc
Interv Radiol. 28:1503–1511.e2. 2017. View Article : Google Scholar
|
|
39
|
Tang YA, Chen YF, Bao Y, Mahara S, Yatim
SMJM, Oguz G, Lee PL, Feng M, Cai Y, Tan EY, et al: Hypoxic tumor
microenvironment activates GLI2 via HIF-1α and TGF-β2 to promote
chemoresistance in colorectal cancer. Proc Natl Acad Sci USA.
115:E5990–E5999. 2018. View Article : Google Scholar
|
|
40
|
Covello KL, Kehler J, Yu H, Gordan JD,
Arsham AM, Hu CJ, Labosky PA, Simon MC and Keith B: HIF-2alpha
regulates Oct-4: Effects of hypoxia on stem cell function,
embryonic development, and tumor growth. Genes Dev. 20:557–570.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Yuan L, Jiang ZM, Chen XH, Bian XY, Li YX,
Ma XF and Liu XZ: Hypoxia inducible factor-1α deSUMOylation reduces
the stemness maintenance ability of endometrial cancer stem cell
and increases its chemosensitivity. Zhonghua Yi Xue Za Zhi.
97:3579–3582. 2017.In Chinese. PubMed/NCBI
|
|
42
|
Liebelt F and Vertegaal AC:
Ubiquitin-dependent and independent roles of SUMO in proteostasis.
Am J Physiol Cell Physiol. 311:C284–C296. 2016. View Article : Google Scholar : PubMed/NCBI
|
